US appeals court declines J&J bid to stop generic Zytiga sales
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate cancer drug Zytiga from hitting the U.S. market. REUTERS: A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate cancer drug Zytiga from hitting the U.S. market.
from Biotech News
0 Comments